b 213 750 (Niacin Extended-Release 750 mg)
Pill with imprint b 213 750 is White, Capsule-shape and has been identified as Niacin extended-release 750 mg. It is supplied by Teva Pharmaceuticals USA Inc..
Niacin is used in the treatment of high cholesterol; depression; niacin deficiency; hyperlipoproteinemia; pellagra (and more), and belongs to the drug classes miscellaneous antihyperlipidemic agents, vitamins. Risk cannot be ruled out during pregnancy. Niacin 750 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for b 213 750
Niacin extended-release
- Imprint:
- b 213 750
- Strength:
- 750 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- Miscellaneous antihyperlipidemic agents
Vitamins - Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Teva Pharmaceuticals USA Inc.
- National Drug Code (NDC):
- 00093-7393
More about niacin
- Niacin Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 72 Reviews – Add your own review/rating
- Drug class: miscellaneous antihyperlipidemic agents
Consumer resources
- Niacin
- Niacin Capsules and Tablets
- Niacin Controlled-Release Capsules and Controlled-Release Tablets
- Niacin (Advanced Reading)
Other brands: Niaspan, Niacor, Slo-Niacin, Nicotinex, ... +3 more
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
